T 0223/11 (Ibandronic acid/HOFFMANN - LA ROCHE) of 22.05.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T022311.20120522
- Date of decision
- 22 May 2012
- Case number
- T 0223/11
- Petition for review of
- -
- Application number
- 03722591.9
- IPC class
- A61P 19/10A61K 31/663
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Ibandronic acid for the treatment and prevention of osteoporosis
- Applicant name
- F. Hoffmann-La Roche AG
- Opponent name
- Laboratorios Liconsa, S.A.
Alfred E. Tiefenbacher GmbH & Co. KG
Teva Pharmaceutical Industries LTD.
Gedeon Richter Plc.
Generics [UK] Limited
Synthon BV
Intervener:
Sandoz Farmacêutica, Lda. - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 105(1)(a)European Patent Convention Art 115European Patent Convention Art 123(2)
- Keywords
- All requests: added subject-matter (yes)
Admissibility of intervention (no)
Referral to the Enlarged Board of Appeal (no) - Catchword
- -
- Cited cases
- T 0016/05
- Citing cases
- T 0689/19
ORDER
For these reasons it is decided that:
1. The intervention is inadmissible.
2. The decision under appeal is set aside.
3. The patent is revoked.
4. The request for a referral to the Enlarged Board of Appeal is refused.